LGALS3 and diabetes mellitus: Pharmacological inhibition (TD139) as well as knockout of Galectin-3 gene both attenuated Galectin-3–mediated suppression of regulatory T cells (Treg cells) and protected from insulitis and diabetes onset in NOD mice.